Linda Schellhammer studied Biology at the University of Fribourg, Switzerland and continued her education at the University of Zurich. She earned her Master Degree in Immunology, working on the development of antibody-like proteins for cancer treatment. A SNF grant allowed her to continue the project for another year, before starting her PhD studies in the development of local brain cancer treatment. Having a keen interest in immunology she is driven to study how it can be applied in the design and development of better cancer therapies.
